NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, including those who have relapsed or are refractory to checkpoint inhibitors, a multi-billion dollar pillar of cancer care,...
Christmas Adventure Awaits: Ausom Ignites the Holidays with High-Performance E-Scooters
LOS ANGELES, Dec. 10, 2025 /PRNewswire/ -- As the festive season brings both cheer and the familiar challenge of last-minute gifting and holiday traffic, Ausom presents the ultimate solution. From December 3 to December 31, 2025, Ausom brings...
Sands China Celebrates 10th Anniversary of Local SME Supplier Support Programme and Hosts Supplier Excellence Awards
Anniversary publication marks long-term SME support for diversified development MACAO, Dec. 9, 2025 /PRNewswire/ -- Sands China celebrated the 10th anniversary of its Local Small, Medium and Micro Suppliers Support Programme with a ceremony Tuesday...
Imec mitigates thermal bottleneck in 3D HBM-on-GPU architectures using a system-technology co-optimization approach
Holistic system-technology co-optimization (STCO) approach key in reducing peak GPU and HBM temperatures under AI workloads while enhancing performance density of future GPU-based architectures LEUVEN, Belgium, Dec. 9, 2025 /PRNewswire/ -- Imec...
STRADVISION Announces Next Phase of Cloud-Driven Innovation in Collaboration with AWS
- Head of Data Innovation Center presents STRADVISION's next roadmap at AWS re:Invent SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- STRADVISION, a global leader in AI-based vision perception technology for vehicles, today announced its...
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF) compared with placebo1 Holistic benefit: secondary endpoints showed significant...
Prof. Gang Shen's Research Paper about Mandibular Advancement Repositioning Technology in the Journal of Aligner Orthodontics
SHANGHAI, Dec. 5, 2025 /PRNewswire/ -- A clinical study developed by Professor Gang Shen's Orthodontic Team from Taikang Bybo Dental has been officially published in the Journal of Aligner Orthodontics (JAO). The article presents key findings on the...
ANTA Makes Its Debut at The Running Event, Unveils New Tech Lineup with Kenenisa Bekele
SAN ANTONIO, Dec. 5, 2025 /PRNewswire/ -- Founded in 1991, ANTA Sports Products Limited has built a robust multi-brand portfolio over the past three decades. Today, it stands among the world' top three sportswear companies. Staying true to its...
INPARADISE Launches New Global Culinary Initiative "TASTE THE WORLD, INPARADISE"
Debuts First Chapter: A Taste Journey Through Italy Featuring Gambero Rosso–Recognized Chef Enrico Negrini TAIPEI, Dec. 5, 2025 /PRNewswire/ -- INPARADISE, Taipei's acclaimed sky-high buffet brand, announces the launch of its new annual...
Electrolux Group hosts Capital Markets Update: Presents updated strategy and reconfirms financial targets, with focus on organic sales
Electrolux Group is hosting a Capital Markets Update in Stockholm and online today, where it will offer an updated view of the company's strategic direction along with reconfirmed financial targets. Updated strategy to be presented at Capital...